Established in 2016 as a spin off project of research institution of the Medical School of the University of Dijon, France Our mission is to detect different areas of the heart in order to quantify clinical parameters and aid cardiac diagnosis. Our main product : QIR (CE-marked and FDA) is a cardiac MRI analysis software that reduces the physician's working time by a factor of 10, and covers all his clinical needs while including a unique solution for myocardial infarction analysis. Selling the QIR Suite 4.1, an imaging analysis software for cardiovascular MRI, 4D flow, in Europe, North America, South America, Japan, and China The solution is validated by over 40 scientific publications and a scientific committee. QIR MR received the EU CE, US FDA, Japan PMDA, Brazil ANVISA and Taiwan FDA. China NMPA application in progress Commercialization began in 2022, with QIR Suite 4.1 being used in over 40 centres worldwide. We look forward to welcoming you and showing you our latest features at Booth 34.
Casis
